Phenoxybenzamine

Chemical formula: C₁₈H₂₂ClNO  Molecular mass: 303.826 g/mol  PubChem compound: 4768

Active ingredient description

Phenoxybenzamine is a non competitive long acting α-adrenergic receptor antagonist.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC Group Classification
C04AX02 Phenoxybenzamine C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AX Other peripheral vasodilators
Discover more medicines within C04AX02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Document Type Information Source  
 PHENOXYBENZAMINE Capsules MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 59-96-1
CAS Substance: 63-92-3
DrugBank Drug: DB00925
PubChem Compound: 4768
RxNorm Ingredient: 8149
SNOMED-CT Concept: 372838003
Phenoxybenzamine (substance)
UNII Identifier: 0TTZ664R7Z
PHENOXYBENZAMINE

Medicines

Phenoxybenzamine is an active ingredient of these brands:

Australia (AU)

Austria (AT)

New Zealand (NZ)

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈